Sivelestat sodium hydrate

DRUG3 trials

Sponsors

Ono Pharmaceutical Co. Ltd, Yokohama City University Medical Center, Kyushu University

Conditions

Acute Lung InjuryEsophageal CancerNeuromyelitis Optica Spectrum Disorder AttackSystemic Inflammatory Response Syndrome

Phase 1

Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

Not yet recruitingNCT07738952

Kyushu UniversityNeuromyelitis Optica Spectrum Disorder Attack

Start: 2026-08-17End: 2028-05-31Target: 7Updated: 2026-07-31

Phase 4

Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan

CompletedNCT00219375

Ono Pharmaceutical Co. LtdAcute Lung Injury, Systemic Inflammatory Response Syndrome

Start: 2004-06-30Updated: 2015-04-23

Unknown Phase

Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy

CompletedNCT01170845

Yokohama City University Medical CenterEsophageal Cancer

Start: 2007-03-31End: 2009-03-31Updated: 2010-07-27